Catecholamines 1972
DOI: 10.1007/978-3-642-65249-3_14
|View full text |Cite
|
Sign up to set email alerts
|

Adrenergic False Transmitters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

1975
1975
1983
1983

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 113 publications
0
9
0
Order By: Relevance
“…of noradrenergic and 5-hydroxytryptaminergic neurones, are able to take up and accumulate amines other than those which they contain under physiological conditions. For instance, in the central nervous system L-DOPA causes an accumulation of dopamine not only in dopaminergic but also in 5-hydroxytryptaminergic neurones (Bartholini, Da Ng, Chase, Colburn & Kopin, 1970), and a-methyl-dopa leads to an increase of ct-methyl-dopamine and a-methyl-noradrenaline in catecholaminergic neurones (Muscholl, 1972).…”
Section: Introductionmentioning
confidence: 99%
“…of noradrenergic and 5-hydroxytryptaminergic neurones, are able to take up and accumulate amines other than those which they contain under physiological conditions. For instance, in the central nervous system L-DOPA causes an accumulation of dopamine not only in dopaminergic but also in 5-hydroxytryptaminergic neurones (Bartholini, Da Ng, Chase, Colburn & Kopin, 1970), and a-methyl-dopa leads to an increase of ct-methyl-dopamine and a-methyl-noradrenaline in catecholaminergic neurones (Muscholl, 1972).…”
Section: Introductionmentioning
confidence: 99%
“…Metaraminol is taken up by a process which is not stimulated by ATPMg2+, not inhibited by reserpine, and which, although possibly carrier mediated, saturates only at extremely high substrate concentrations (53). The physiological relevance of this second type uptake is unclear (52), but it is o f consid erable pharmacological importance in permit ting 'false transmitters' (such as metaraminol) to enter the vesicles and exert their pharmaco logical effects (37). Additionally, measurement o f the uptake o f metaraminol relative to that of catecholamines is o f value in utilization of uptake as a tool in physiological and pharmaco logical studies (vide infra).…”
Section: Is Vesicular Catecholamine Uptake Actually a Transport Process?mentioning
confidence: 99%
“…The transport site in the vesicle mem brane is thus far more primitive in its selectivity than its uptake!, and is also less specific than the intravesicular storage complex (55). The greater selectivity o f the storage site within the synaptic vesicle compared to the transport site would appear to play a greater role than does vesicular transport in determining which amines can remain within the vesicle to act as catechol amine displacers or false transmitters (37,55).…”
Section: Characteristics Of the Vesicular Transport Sitementioning
confidence: 99%
“…We have no direct evidence why adrenaline should be the least affected of the hypothalamic catecholamines after chronic a-methyldopa treatment, but this result was certainly not due to methodological problems associated with the radioenzymatic assay, since the methoxy derivative of adrenaline was always fully separated from those of all other catecholamines on paper chromatography. There has been some speculation whether a-methyladrenaline is formed in nervous tissue (Muscholl, 1972). Although a-methyladrenaline has been reported to be present in appreciable amounts only in tissues with high PNMT activity (e.g., adrenal gland; Muscholl, 1972), and hypothalamic PNMT activity is only about 2% of that found in the adrenal, the amine could still be found in trace, but important, amounts.…”
Section: Discussionmentioning
confidence: 94%
“…There has been some speculation whether a-methyladrenaline is formed in nervous tissue (Muscholl, 1972). Although a-methyladrenaline has been reported to be present in appreciable amounts only in tissues with high PNMT activity (e.g., adrenal gland; Muscholl, 1972), and hypothalamic PNMT activity is only about 2% of that found in the adrenal, the amine could still be found in trace, but important, amounts. In fact further investigations have indicated that in vitro a-methylnoradrenaline is a substrate for hypothalamic PNMT (P. M. Beart & W. J. Louis, unpublished observations) and thus a-methyladrenaline could be formed in the brain if a-methylnoradrenaline is available to PNMT.…”
Section: Discussionmentioning
confidence: 94%